NexImmune, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SLATE PATH CAPITAL LP | 11/14/2023 | 925,000 | $194,158 | 0.00% | 3.55% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2023 | 801,371 | $168,208 | 0.00% | 3.07% |
| ALLEN OPERATIONS LLC | 11/13/2023 | 635,934 | $133,546 | 0.00% | 2.44% |
| EPIQ CAPITAL GROUP, LLC | 11/08/2023 | 390,600 | $81,987 | 0.00% | 1.50% |
| RAYMOND JAMES & ASSOCIATES | 10/24/2023 | 320,622 | $67,299 | 0.00% | 1.23% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/13/2023 | 316,039 | $66,368 | 0.00% | 1.21% |
| FIRST MANHATTAN CO. LLC. | 11/14/2023 | 149,110 | $31,298 | 0.00% | 0.57% |
| M28 CAPITAL MANAGEMENT LP | 11/13/2023 | 133,442 | $28,009 | 0.00% | 0.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/13/2023 | 108,143 | $21,628 | 75.18% | 0.41% |
| CAPROCK GROUP, LLC | 10/18/2023 | 103,482 | $21,721 | 0.00% | 0.40% |
| VANGUARD GROUP INC | 12/18/2023 | 97,320 | $20,427 | 0.00% | 0.37% |
| COMERICA BANK | 11/21/2023 | 81,421 | $17,090 | 100.00% | 0.31% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2023 | 65,500 | $14,000 | 15.72% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2023 | 50,000 | $10,000 | 0.00% | 0.19% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2023 | 46,660 | $9,332 | -21.70% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2023 | 35,421 | $7,084 | 221.60% | 0.14% |
| BANK OF MONTREAL /CAN/ | 11/01/2023 | 32,000 | $8,176 | 0.00% | 0.12% |
| STATE STREET CORP | 11/14/2023 | 22,919 | $4,584 | 0.00% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 11/14/2023 | 21,845 | $4,585 | -7.95% | 0.08% |
| BAADER BANK AKTIENGESELLSCHAFT | 11/14/2023 | 17,251 | $3,226 | 8.64% | 0.07% |
| NORTHERN TRUST CORP | 11/13/2023 | 12,668 | $2,659 | 0.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2023 | 10,077 | $2,115 | -55.37% | 0.04% |
| SMITH, SALLEY & ASSOCIATES | 10/27/2023 | 10,000 | $2,099 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2023 | 6,390 | $1,342 | -0.03% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2023 | 1,000 | $210 | 66.67% | 0.00% |
| MORGAN STANLEY | 11/15/2023 | 446 | $94 | 100.00% | 0.00% |
| BLACKROCK INC. | 11/13/2023 | 360 | $76 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2023 | 126 | $26 | -9.35% | 0.00% |
| UBS GROUP AG | 11/09/2023 | 49 | $10 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/13/2023 | 4 | $1 | 100.00% | 0.00% |
| DAVENPORT & CO LLC | 10/17/2023 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2023 | 0 | $0 | -100.00% | 0.00% |
NexImmune, Inc.institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of NexImmune, Inc.. The most heavily invested institutionals were:
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 19,190
Amalgamated Financial Corp.: 2,752
DSAM Partners (London) Ltd: 0
16.85% of NexImmune, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 21,942 shares in the last 24 months. This purchase volume represents approximately $4,388 in transactions.